Skip to main content

letter

. 1996 Apr 6;312(7035):909–910. doi: 10.1136/bmj.312.7035.909b

Cost effectiveness of antenatal screening for cystic fibrosis. Study might be better described as a cost description of screening.

PMCID: PMC2350572 PMID: 8611897

909

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cuckle H. S., Richardson G. A., Sheldon T. A., Quirke P. Cost effectiveness of antenatal screening for cystic fibrosis. BMJ. 1995 Dec 2;311(7018):1460–1464. doi: 10.1136/bmj.311.7018.1460. [DOI] [PMC free article] [PubMed] [Google Scholar]
Elborn J. S., Shale D. J., Britton J. R. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax. 1991 Dec;46(12):881–885. doi: 10.1136/thx.46.12.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lieu T. A., Watson S. E., Washington A. E. The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol. 1994 Dec;84(6):903–912. [PubMed] [Google Scholar]
Watson E. K., Mayall E. S., Lamb J., Chapple J., Williamson R. Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):217–220. doi: 10.1016/0140-6736(92)90477-k. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES